Study guide
2.5 Fetal Growth Disorders & Amniotic Fluid Complications
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
2.5 Fetal Growth Disorders & Amniotic Fluid Complications
Key Takeaways Explain This Topic AI
Fetal Growth Restriction (FGR) is clinically defined by sonographic estimated fetal weight (EFW) or abdominal circumference (AC) <10th percentile; severe FGR is defined as <3rd percentile.
Symmetrical FGR (early onset, normal HC/AC ratio) results from early chromosomal or congenital infectious insults; Asymmetrical FGR (late onset, elevated HC/AC ratio, 'head-sparing') results from chronic uteroplacental insufficiency.
Umbilical artery Doppler velocimetry guides delivery timing: Absent End-Diastolic Velocity (AEDV) triggers delivery at 33 0/7 to 34 0/7 weeks, while Reversed End-Diastolic Velocity (REDV) triggers delivery at 30 0/7 to 32 0/7 weeks.
Oligohydramnios (AFI <5.0 cm or MVP <2.0 cm) increases risks of severe umbilical cord compression, pulmonary hypoplasia, and Potter sequence; managed with intensive fetal surveillance and delivery at 36 0/7 to 37 6/7 weeks.
Polyhydramnios (AFI ≥24.0 cm or MVP ≥8.0 cm) carries critical intrapartum risks of umbilical cord prolapse and acute placental abruption upon membrane rupture, as well as severe postpartum hemorrhage from uterine atony.
Last updated: August 2026
Fetal Growth Restriction (FGR / IUGR)
Fetal Growth Restriction (FGR) —historically termed Intrauterine Growth Restriction (IUGR)—is defined by ACOG and the Society for Maternal-Fetal Medicine (SMFM) as a sonographically Estimated Fetal Weight (EFW) or Abdominal Circumference (AC) <10th percentile for gestational age.
Severe FGR: EFW <3rd percentile for gestational age.
Small for Gestational Age (SGA): Defined at birth when neonatal birth weight is <10th percentile. (Some SGA infants are constitutionally small but genetically normal, whereas FGR represents pathologic in utero growth failure). [ SYMMETRICAL VS. ASYMMETRICAL FGR ]
- Feature Symmetrical FGR (Early) Asymmetrical FGR (Late)
- ─────────────────────────────────────────────────────────────────────────────────
- Timing of Insult Early (<16–20 weeks) Late (Late 2nd / 3rd trimester)
- Cellular Phase Hyperplastic (cell division) Hypertrophic (cell enlargement)
- Proportions Global reduction (HC, AC, FL) Head-sparing (Normal HC/FL, small AC)
- HC / AC Ratio Normal Elevated (>95th percentile)
- Primary Etiologies Aneuploidy, TORCH infections Uteroplacental insufficiency, HTN
- Prognosis Guarded / poor neurodevelopment Favorable if delivered timely
- Pathophysiological Subtypes of FGR
Symmetrical FGR (~20% to 30% of cases):
Results from early, intrinsic pathological insults occurring during the cellular hyperplasia phase (<16–20 weeks).
All biometric parameters—Head Circumference (HC), Biparietal Diameter (BPD), Abdominal Circumference (AC), and Femur Length (FL)—are proportionately reduced <10th percentile. The HC/AC ratio remains normal .
Etiologies: Chromosomal aneuploidies (Trisomy 18, Trisomy 13, Triploidy), early congenital TORCH infections (Cytomegalovirus [CMV], Toxoplasmosis, Rubella), severe maternal substance abuse, and early teratogen exposure.
Prognosis: Guarded; high rate of permanent neurodevelopmental impairment.
Asymmetrical FGR (~70% to 80% of cases):
Results from extrinsic insults during the cellular hypertrophy phase in the late second or third trimester.
Characterized by the "head-sparing" physiological adaptation : in response to chronic hypoxia, fetal chemoreceptors trigger preferential blood flow redistribution to the vital organs (brain, myocardium, adrenal glands) at the expense of somatic organs (liver, kidneys, subcutaneous adipose tissue, skeletal muscle). The fetal head (HC, BPD) and femur (FL) are relatively preserved at normal percentiles, while the abdominal circumference (AC) is severely diminished (<10th percentile) due to depleted hepatic glycogen stores and reduced abdominal fat. The HC/AC ratio is elevated .
Etiologies: Uteroplacental insufficiency secondary to maternal hypertensive disorders (preeclampsia, chronic hypertension), severe pregestational diabetes with vascular disease, antiphospholipid syndrome, chronic renal disease, systemic lupus erythematosus (SLE), and severe cigarette smoking.
Prognosis: Favorable with timely delivery before the onset of irreversible metabolic acidosis.
Doppler Velocimetry & Antenatal Surveillance in FGR
Doppler velocimetry provides critical hemodynamic assessment of fetoplacental vascular resistance and cardiac function, serving as the primary tool to determine the timing of delivery. [ UMBILICAL ARTERY DOPPLER PROGRESSION ]
1. Normal Flow ███████
(Low resistance) █████████ Low resistance, high continuous forward end-diastolic flow.
███████████
2. Decreased Flow ████
(High resistance) ██████ Elevated S/D ratio; increased placental vascular resistance.
████████
- 3. Absent Flow (AEDV) ███
- █████ End-diastolic flow reaches baseline (0 velocity);
███████ >60–70% placental obliteration. Deliver at ≥33–34w.
4. Reversed Flow (REDV) ███
█████ Retrograde flow during diastole; >80% placental obliteration.
─────── High risk of imminent stillbirth! Deliver at ≥30–32w.
- ███ (Reverse)
- Doppler Assessment Vessels & Clinical Triggers
Umbilical Artery (UA) Doppler: Assesses downstream placental vascular resistance.
Decreased Diastolic Flow (Elevated S/D Ratio): Indicates increasing placental resistance; managed with weekly Doppler surveillance.
Absent End-Diastolic Velocity (AEDV): Indicates >60% to 70% obliteration of the placental tertiary villous vascular bed. Delivery indicated at ≥ 33 0/7 to 34 0/7 weeks \ge 33\text{ 0/7 to } 34\text{ 0/7 weeks} ≥ 33 0/7 to 34 0/7 weeks (or earlier if other testing is abnormal).
Reversed End-Diastolic Velocity (REDV): Indicates >80% obliteration of placental vasculature with retrograde diastolic flow back toward the fetal heart. High risk of imminent fetal acidemia and intrauterine demise. Delivery indicated at ≥ 30 0/7 to 32 0/7 weeks \ge 30\text{ 0/7 to } 32\text{ 0/7 weeks} ≥ 30 0/7 to 32 0/7 weeks following antenatal corticosteroid course and inpatient monitoring.
Middle Cerebral Artery (MCA) Doppler: Demonstrates cerebral vasodilation (decreased pulsatility index [PI] <5th percentile) reflecting the active "brain-sparing" reflex.
Ductus Venosus (DV) Doppler: Reflects right ventricular afterload and central venous pressure. Absent or reversed flow during atrial contraction ('a-wave') is an ominous late finding indicating impending myocardial failure, severe metabolic acidemia, and imminent stillbirth.
SMFM Evidence-Based Delivery Timing for FGR
FGR (EFW 3rd–10th percentile) with normal Dopplers: Delivery at 38 0/7 to 39 6/7 weeks .
Severe FGR (EFW <3rd percentile) with normal Dopplers: Delivery at 37 0/7 weeks .
FGR with Decreased Diastolic Flow (elevated S/D): Delivery at 37 0/7 weeks .
FGR with Absent End-Diastolic Velocity (AEDV): Delivery at 33 0/7 to 34 0/7 weeks .
FGR with Reversed End-Diastolic Velocity (REDV): Delivery at 30 0/7 to 32 0/7 weeks .
Fetal Macrosomia & Large for Gestational Age (LGA)
Definitions:
Large for Gestational Age (LGA): Sonographic EFW or birth weight >90th percentile for gestational age.
Fetal Macrosomia: Absolute neonatal birth weight >4,000 g or >4,500 g regardless of gestational age. (ACOG formally defines macrosomia as birth weight >4,500 g).
Pathophysiology (The Pedersen Hypothesis): Maternal hyperglycemia → \rightarrow → increased transplacental glucose transfer → \rightarrow → persistent fetal hyperglycemia → \rightarrow → fetal pancreatic beta-cell hyperplasia and hyperinsulinemia → \rightarrow → excessive fat deposition and somatic tissue hypertrophy (especially across the shoulders and trunk).
Risk Factors: Pre-gestational and gestational diabetes mellitus, maternal pre-pregnancy obesity (BMI >30), excessive gestational weight gain, multiparity, post-term pregnancy (>41 weeks), history of prior macrosomic neonate, and male fetal sex.
Clinical Complications:
Maternal: Labor arrest, operative vaginal delivery (forceps/vacuum), severe 3rd- and 4th-degree perineal lacerations, emergency cesarean delivery, and severe postpartum hemorrhage (PPH) due to uterine atony from myometrial overdistention.
Neonatal: Shoulder dystocia , brachial plexus injuries ( Erb-Duchenne palsy [C5–C6], Klumpke palsy [C8–T1]), clavicle and humerus fractures, perinatal asphyxia, neonatal hypoglycemia (rebound hyperinsulinemia after umbilical cord clamping), polycythemia, and neonatal hyperbilirubinemia.
ACOG Delivery Guidance: Scheduled elective cesarean delivery may be offered for estimated fetal weight >4,500 g in diabetic individuals or >5,000 g in non-diabetic individuals .
Amniotic Fluid Volume Disorders
Amniotic fluid is in continuous dynamic equilibrium throughout pregnancy. In the second and third trimesters, primary fluid production occurs via fetal urine (~600–1,000 mL/day at term) and fetal lung fluid secretion (~300–400 mL/day). Primary resorption occurs via fetal swallowing (~500–800 mL/day) and intramembranous absorption.
Diagnostic Measurement Methods
Amniotic Fluid Index (AFI): Sum of the deepest vertical fluid pockets in each of the four uterine quadrants (free of umbilical cord and fetal extremities).
Maximum Vertical Pocket (MVP / Single Deepest Pocket): Vertical depth of the single largest fluid pocket free of cord and fetal limbs.
Master Comparative Table: Oligohydramnios vs. Polyhydramnios
Diagnostic Dimension Oligohydramnios Polyhydramnios
Sonographic Criteria AFI <5.0 cm OR MVP <2.0 cm AFI ≥ 24.0 cm \ge 24.0\text{ cm} ≥ 24.0 cm OR MVP ≥ 8.0 cm \ge 8.0\text{ cm} ≥ 8.0 cm ; • Mild: AFI 24–29.9 cm (MVP 8–11.9 cm); • Moderate: AFI 30–34.9 cm (MVP 12–15.9 cm); • Severe: AFI ≥ 35 cm \ge 35\text{ cm} ≥ 35 cm (MVP ≥ 16 cm \ge 16\text{ cm} ≥ 16 cm )
Underlying Etiologies • PPROM (most common cause); • Uteroplacental insufficiency / fetal hypoxia (renal hypoperfusion → \rightarrow → oliguria); • Fetal renal agenesis ( Potter sequence ) / urethral obstruction; • Post-term pregnancy (>41 weeks); • Medications: NSAIDs / indomethacin (decreased renal blood flow), ACE inhibitors (renal dysgenesis) • Idiopathic (50% to 60% of cases); • Maternal Diabetes (osmotic diuresis from fetal hyperglycemia); • Fetal GI atresias (esophageal atresia, duodenal atresia ["double bubble"] ); • Fetal CNS/neuromuscular disorders (impaired swallowing); • Monochorionic TTTS (recipient twin); • High-output fetal hydrops / severe anemia
Fetal & Neonatal Risks • Umbilical cord compression (severe variable decelerations); • Thick meconium aspiration syndrome; • Pulmonary hypoplasia (if prolonged in 2nd trimester); • Musculoskeletal compression deformities (clubfoot, Potter facies) • Fetal malpresentation (unstable lie, breech, transverse); • Umbilical Cord Prolapse upon rupture of membranes; • Preterm labor & PPROM from uterine overdistention; • Fetal macrosomia
Maternal Risks & Complications • Increased cesarean delivery rate for fetal distress; • Prolonged labor • Severe maternal dyspnea, orthopnea, abdominal pain; • Placental Abruption upon sudden amniotic fluid decompression; • Postpartum Hemorrhage from severe uterine atony
Clinical & Intrapartum Management • Workup for membrane rupture (ferning, pooling, nitrazine); • Serial twice-weekly NST and MVP surveillance; • Maternal oral hydration; • Intrapartum Amnioinfusion via IUPC for recurrent variable decels; • Delivery timing: 36 0/7 to 37 6/7 weeks (isolated) • Detailed anatomic ultrasound, glucose screening, antibody titers; • Therapeutic Amnioreduction for severe maternal dyspnea; • Intrapartum: Controlled slow rupture of membranes (needle decompression) with fetal head engaged to prevent cord prolapse and abruption; • Proactive PPH uterotonic preparation